Review Article

A Clinical Review for Guillain-Barré Syndrome

DOI https://doi.org/10.70302/jpsim.v7i4.2658
Received: 12 Jun 2026 Revised: 21 Aug 2026 Accepted: 28 Oct 2026 Published Online: 20 Nov 2026

Abstract

GB syndrome is a common clinical presentation in medical emergency wards and the ICU. It can lead to higher mortality. Trainees find it hard to differentiate GB syndrome from other causes of weakness, especially spinal cord pathologies. The complications of the disease can be devastating if not identified & managed in a timely and appropriate manner. As the initial investigations may not confirm the diagnosis, it remains a clinical judgement for the early course of the disease.
This review focuses on the various clinical, radiological, and histological clues, especially for our junior colleagues, based on international guidelines. The purpose is to provide a clear understanding and approach to managing such cases.

Keywords:
GB syndrome poly-radiculopathy acute peripheral neuropathies

How to Cite This Article

Hussain A, Avais J. A Clinical Review for Guillain-Barré Syndrome. J Pak Soc Intern Med. 2026;7(4):284–293. doi:10.70302/jpsim.v7i4.2658

⭳ Download XML (JATS)

Conflict of Interest

None

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

None

Funder information follows the Crossref Funder Registry standard.

Author Contributions

AH: Conception.
JA: Design of the work.
AH, JA: Data acquisition, analysis, or interpretation.
AH: Draft the work.
JA: Review critically for important intellectual content.
All authors approve the version to be published.
All authors agree to be accountable for all aspects of the work.

Contributions are recorded against the ICMJE criteria for authorship.

References

  1. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397(10280):1214-1228
  2. Kouton L, Boucraut J, Devaux J. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins. Clin Neurophysiol 2020;131:921–7
  3. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y. Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol. 2012;42(2):121-30
  4. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366(24):2294-304.
  5. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, et. al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671-683
  6. Oh SJ, LaGanke C, Claussen GC. Sensory Guillain-Barré syndrome. Neurology. 2001;56(1):82-6.
  7. Wakerley BR, Yuki N. Isolated facial diplegia in Guillain-Barré syndrome: Bifacial weakness with paresthesias. Muscle Nerve. 2015;52(6):927-32
  8. Yuki N, Kokubun N, Kuwabara S, Sekiguchi Y, et. al. Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol. 2012;259(6):1181-90.
  9. Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010;41(2):202-207.
  10. Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11): 671-683.
  11. Verboon C, Doets AY, Galassi G, et al. Current treatment practice of Guillain-Barré syndrome. Neurology. 2019;93(1):e59-e76
  12. Yuki N, Kokubun N, Kuwabara S, et al. GuillainBarré syndrome associated with normal or exaggerated tendon reflexes. J Neurol 2012; 259(6):1181-90.
  13. Shahrizaila N, Lehmann HC, Kuwabara S. GuillainBarré syndrome. Lancet Lond Eng. 2021; 397(10280):1214-28.
  14. Scarpino M, Lolli F, Carrai R, Lanzo G, et. al. Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study. Neurophysiol Clin. 2016 Feb;46(1):35-42.
  15. Walgaard C, Lingsma HF, Ruts L, Drenthen J, et. al. Prediction of respiratory insufficiency in Guillain-Barré syndrome. Ann Neurol. 2010;67(6):781-7.
  16. WDerksen A, Ritter C, Athar P, Kieseier BC. Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics. Muscle Nerve. 2014;50(5):780-4.
  17. Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010;41(2):202-7.
  18. Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2017;2(2):CD001798.
  19. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014;2014(9):CD002063.
  20. Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130(Pt 9):2245-57.
  21. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80(18):1650-4.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2026 The Author(s).